Dr. Md Sabir Alam’s main area of research is Pharmaceutical Nanotechnology and its Biomedical application with a specialization in Drug delivery for various targeted diseases, including Psoriasis, Neurological disorders, Cancer targeting, Antimicrobial, and Antimalarial Activity. Currently working as an Associate Professor at the Department of Pharmaceutics, SGT College of Pharmacy, SGT University Gurgaon, Haryana, India. He has ten years of teaching and research experience. He has authored more than 30 research and review articles in international peer-reviewed journals, 1 Book, 35 Book chapters, and 4 Patents. His area of interest includes Synthesis, Characterization Application of Various Nanocarriers for drug delivery/delivery for treating Neurological disease, Cancer, and Malarial disease.
EDUCATION
In my Ph.D. research work, I successfully developed another novel approach for designing of Polymer-based gold Nanoparticles and their impacts on Microbial disease and DNA Damage activity; being used for diagnosis purposes. Developed Gold Nano formulation for their unique geometrical morphology, significantly effective against multi-drug resistance microbial disease because of their unique mechanism of action which imparts antimicrobial effects and apoptosis in cancer cells. I preferred to explore a better understanding of different phenomena, prediction of end performance parameters, and minimize the usage of resources, by integrating different tools of In-silico drug designing for enhancement of end product performance. During the process I am collaborating with various organizations for research like AIIMS for SEM and TEM Characterization, JNU for Microbial activity, GGSIP University for Antimicrobial and DNA Damage Activity.
Recent innovations in nanomedicine and nano-based techniques for the treatment of breast cancer Meena Bhandari, Seema Raj, Md Sabir Alam Bioimpacts, 2025 Breast cancer (BC) is a persistent global health challenge, necessitating innovative therapeutic strategies. Recently, nanotechnology has appeared as a transformative methodology to treat BC, suggesting precise targeting, controlled drug delivery, and improved imaging capabilities. This review offers a current overview of the latest innovations around nanotechnology for BC therapy in the field of new nanomedicines and nano-based drug delivery methods by carefully examining the utilization of nanoparticles to enhance the effectiveness of both new and old medications and to enable targeted evaluation using disease markers. Key topics include early detection, targeted drug delivery, multimodal imaging, and combination therapies. The paper underscores the probability of using nanotechnology to reshape BC management landscape and outlines potential future directions.
The treatment of psoriasis via herbal formulation and nano-polyherbal formulation: A new approach Tejpal Yadav, Hemant Kumar Singh Yadav, Abhay Raizaday, Md Sabir Alam Bioimpacts, 2025 Psoriasis is a chronic condition that can strike at any age. This sickness is associated with inflammatory problems that impact all humans in the world. Psoriasis is more common in Scandinavians than in Asian and African populations due to a combination of factors such as age, gender, geographic location, ethnicity, genetic and environmental factors. Immune stimulation, genetic contribution, antimicrobial peptides, and other significant triggers such as medicines, immunizations, infections, trauma, stress, obesity, alcohol intake, smoking, air pollution, sun exposure, and particular disorders cause psoriasis. Numerous clinical research investigations are now underway, and therapeutic alternatives are available. However, these therapies only improve symptoms and do not accomplish a complete cure; they also have dangerous and undesirable side effects. Natural products have gained popularity recently due to their great effectiveness, safety, and low toxicity. Natural formulations of various nanocarriers like liposomes, lipospheres, nanogels, emulgel, nanostructured lipid carriers, nanosponge, nanofibers, niosomes, nanomiemgel, nanoemulsions, nanospheres, cubosomes, microneedles, nanomicelles, ethosomes, nanocrystals, and foams, have significantly contributed and encouraged advancement in psoriasis disease treatment. These phytochemical-loaded new nanoformulations address several issues associated with natural products in conventional dosage forms, such as instability, poor solubility, and limited bioavailability. This article reviews some of the intriguing phytochemicals, as well as their possible molecular target locations and mechanisms of action, which may assist in the development of more specific and selective antipsoriatic medicines. Exploring and understanding phytochemicals' functions will allow for more site-specific psoriasis treatment techniques. This review concluded the psoriasis disease with phytoconstituent loaded herbal or polyherbal nanocarriers and their mechanistic approach.
New Aspects of the Medicinal Value of Cornsilk: A Review Priyansha Bhatia, Sushma Chaturvedi, Sonika Shrivastav, Md Sabir Alam Natural Products Journal, 2025 : Cornsilk has been a natural remedy for centuries to treat various medical conditions. Recent research shows the anti-inflammatory activities of cornsilk extract, which can help relieve pain. Certain biopeptides are involved in the induction of anti-inflammatory action in the administration of cornsilk extract. The analgesic activity of cornsilk is due to the presence of tannins and polyphenolic constituents in Zea mays. Besides maysin, many other factors, such as steroids, flavonoids, volatile oils, and various phenolic compounds, make cornsilk extract a modern anti-inflammatory and analgesic drug with minor side effects. In diverse cultures and folk medicines, cornsilk is used for its diuretic properties, reduction in melanin production properties, and antioxidant, anti-inflammatory, and analgesic properties. Silver nanoparticles using a combined extract of cornsilk, parsley, and Arabic gum extract have been reported to reduce inflammation. These effects have been observed in vivo. This formulation has anti-microbial as well as antioxidant properties. This review article focuses on the newer aspects of the medicinal value of cornsilk.
Role of Nanomedicine for Targeted Drug Delivery in Livestock: Future Prospective Neeti Hooda, Aarti Ahlawat, Puja Kumari, Md. Sabir Alam, Jamilur R. Ansari Pharmaceutical Nanotechnology, 2025 Nanotechnology has advanced significantly in recent years and is currently used in a wide range of sectors. Only a handful of the many diverse issues covered by nanotechnology include nanoscale gadgets, nanomaterials, nanoparticles, and nanomedicines. Its performance in treating a range of grave conditions, such as cancer, early detection of infections, analysis, bio-imaging, and bio sensing, suggests that it is highly advanced. Nanoscale materials have been employed for medicine delivery, pharmaceutics, and a range of diagnostic techniques due to their various biochemical and physical features. The use of nanoparticles that are based on nanotechnology can significantly improve the drug delivery mechanism. It is believed that nanoparticles capacity to improve the stability and solubility of drugs and shield them from impulsive inactivation during drug transfer makes it possible for them to capture, encapsulate, or bond with the molecules. The use of nanomedicine or nanoparticle-based tactics to combat viruses has emerged as a potentially life-saving tactic. These approaches have the power to protect both humans and animals against viruses. In order to inactivate a virus, nanoparticles have the unique capacity to connect with the virus epitope. Many nanocarriers have the potential to replace current drug delivery methods with focused drug delivery. Small dosages, low toxicity, and targeted flow of drug release at the infected location are all characteristics of nanocarriers or nanomedicine. Due to their distinct physicochemical and biological features, nanomaterial- based drug delivery systems (NBDDS) are frequently employed to enhance the safety and therapeutic efficacy of encapsulated pharmaceuticals. The program’s objective can be supported by the applications that have so far been developed. This idea is therefore essential and sophisticated for the development of civilization. Our research will therefore concentrate on how human use of nanomedicines has changed through time in many domains.
Eco-friendly Synthesis of Azadirachta indica-based Metallic Nanoparticles for Biomedical Application & Future Prospective Puja Kumari, Laxmi Devi, Renu Kadian, Aafrin Waziri, Md Sabir Alam Pharmaceutical Nanotechnology, 2025 The process of producing the metallic nanoparticles (MNPs) in a sustainable and environment- friendly process is very desirable due to environmental hazards posed by climatic changes. Biomedical one of the fields classified under nanoscience, nanoparticles have a potential synthetic application, which makes it a vast area of research. These particles can be prepared using chemical, physical, and biological methods. One of the methods of synthesis of nanoparticles is by the use of plant extracts, known as green synthesis. Because of its low cost and nontoxicity, it has gained attention in recent times. This review was conducted to find the possible outcomes and uses of metallic nanoparticles synthesized using different parts like gum, root, stem, leaf, fruits, etc. of Azadirachta indica (AI). AI, a popular medicinal plant commonly known as neem, has been studied for the green synthesis of NPs by using the capping and reducing agents secreted by the plant. Various phytochemicals identified in neem are capable of metal ion reduction. Green synthesis of NPs from neem is an eco-friendly and low-cost method. These NPs are reported to exhibit good antimicrobial activity. The review covers the preparation, characterization, and mechanism associated with the antibacterial, anticancer, and neurological diseases of the MNPs. Furthermore, the limitations associated with the existing NPs and the prospects of these NPs are also examined.
An Updated Review on the Alarming Epidemic of the Monkeypox Virus Neelam Singh, Md Sabir Alam, Charu Bharti, Nitin Kumar, Shalini Jayant, et al. Coronaviruses, 2025 : After the COVID-19 pandemic, the world has been vulnerable due to another virus called monkeypox. Monkeypox is a very uncommon zoonotic infectious condition that occurs in both human and non-human primates with similar clinical characteristics as smallpox along with remarkable epidemic potential because of the increasing existence of human outbursts in recent scenarios. The increasing number of cases of this virus is developing curiosity among the people, hence scientists are aiming to become aware of various pathological characteristics and management of this virus before it becomes an epidemic. Currently, the monkeypox outbreak is a trending headline and has increased as an alarming tone after continuous upcoming cases. Previous studies revealed that the first human suspected case was found on September 1, 1970, when a 9-month-old baby was admitted to the Basankusu Hospital in the Democratic Republic of Congo. It is hard to distinguish monkeypox from the smallpox virus therefore, laboratory testing is the technique of disease identification and monitoring. Various new approaches and vaccines are being positioned for the prevention and clinical management of monkeypox through the entanglement of metallic and organic nanocarriers. However, more researchers suggested that virology and ecology of the virus in endemic areas is essential to recognize and avoid further worldwide occurrence of this virus. On behalf of an exhaustive literature survey, We are providing a rationalizing overview of monkeypox in the context of its present global outbreak, as well as its symptoms, prevention, treatment, assessment, and clinical studies.
New approaches of green silver nanoparticles for cancer and biomedical applications: a review Puja Kumari, Khushi Quadri, Renu Kadian, Saloni Mishra, Aafrin Waziri, et al. Exploration of Targeted Anti Tumor Therapy, 2025 The green synthesis of silver nanoparticles (AgNPs) has recently gained prominence as a sustainable and eco-friendly alternative to conventional physical and chemical methods. Utilizing biological entities such as plant extracts, bacteria, fungi, and biomolecules, the method acts by both reducing and stabilizing mechanisms. It does not use any harmful chemical substances, thus proving to be eco-friendly. Green-synthesized AgNPs exhibit enhanced biocompatibility, stability, and targeted delivery of the drug due to the use of naturally derived surface capping agents. These unique characteristics allow selective interference with cancer cells. The mechanism involved is the generation of reactive oxygen species (ROS), the induction of apoptosis, DNA damage, and cell cycle arrest. Green AgNPs also possess broad-spectrum antimicrobial, catalytic, antiparasitic, and anti-inflammatory properties, supporting the fact that they can be utilised in biomedical fields such as drug delivery, bioimaging, biosensing, tissue engineering, and regenerative medicine. Recent advancements have focused on controlling NP size, shape, and surface functionality to maximize efficacy while simultaneously minimizing cytotoxicity. This review provides a comprehensive analysis of the latest green synthesis strategies, their characterizations, and the molecular mechanisms by which they exert anticancer effects. Recent patents highlight the clinical potential of AgNPs in cancer therapy. US Patent 12201650 (2025) describes green synthesis using Caralluma sinaica, while other patents (WO2007001453, US7462753) outline adaptable biomedical formulations. Studies on biogenic AgNPs also show significant tumor inhibition and selective cytotoxicity against cancer cells. Furthermore, the article discusses current biomedical applications and critically evaluates the limitations, such as reproducibility, toxicity concerns, and scalability for clinical translation. Addressing these challenges is essential for the integration of green AgNPs into mainstream cancer therapeutics. The convergence of nanotechnology and biologically derived synthesis opens promising avenues for the development of safe, effective, and environmentally sustainable medical innovations.
Herbal based nanoparticles as a possible and potential treatment of cancer: a review Roshan Yadav, Himmat Singh Chawra, Gaurav Dubey, Md Sabir Alam, Vikram Kumar, et al. Exploration of Targeted Anti Tumor Therapy, 2025 Cancer is the greatest cause of mortality worldwide. Various drug classes treat various cancers. Nanoformulations made from natural sources are being studied for treating several diseases, including cancer. Surgery, chemotherapy, immunotherapy, and radiation have mostly failed to treat cancer. These drugs may damage quickly dividing healthy tissues, structural anomalies, bodily toxicity, long-term side effects, tumor cell drug resistance, and psychiatric disturbances. Researchers are developing nanoscale medicines using natural medications like Malva sylvestris and Curcumin to lower concentrations and improve target specificity. Nanoparticles’ small size and unique properties make them beneficial. They encapsulate medicinal ingredients, improving solubility, medication release, cellular absorption, and delivery. Nanoparticles may better identify and bind to cancer cells when functionalized with ligands. Natural chemicals and nanotechnology may improve medication availability, distribution, and targeting to cancer cells, making cancer treatments more effective and safe. Nanomedicine, which employs nanoparticles to treat cancer and malignant cells, has grown rapidly because nanodrugs are more effective and have fewer side effects than current commercial cancer drugs. Nanotechnology-based natural chemicals and pharmaceutical delivery methods for cancer therapy are covered in this review article. The paper discusses nanoparticle pros and cons and natural chemicals’ cancer-fighting appeal.
Lipid-based nanoparticles: advancing therapeutic strategies for vitiligo management Mahdi Darvishi, Amir Mohammad Chekeni, Mohammad Fazelhosseini, Soheil Rajabalizadeh, Md. Rizwanullah, et al. Bioimpacts, 2025 Vitiligo, a chronic autoimmune disorder characterized by the presence of depigmented skin patches, remains a therapeutic challenge due to its multifactorial pathogenesis and the absence of highly effective treatment options. Although the exact etiology of vitiligo is not fully understood, factors such as genetic factors, oxidative stress, autoimmunity, and inflammation are implicated in the destruction of melanocytes. Current therapeutic strategies primarily focus on modulating immune responses and alleviating oxidative stress. Conventional treatments, including topical corticosteroids, phototherapy, and immunosuppressive agents, often exhibit limited efficacy and are associated with significant side effects, limiting their long-term application. In recent years, nanotechnology has emerged as a transformative approach in drug delivery systems, offering precise targeting, enhanced drug bioavailability, and minimized systemic toxicity. Nanocarrier-based systems especially lipid-based nanoparticles (LNPs) effectively address critical barriers in vitiligo treatment, such as poor drug solubility, rapid degradation, and inadequate skin penetration. Moreover, controlled drug release mechanisms offered by LNPs ensure sustained therapeutic drug levels at the target site, improving efficacy and reducing the frequency of administration. This review provides an overview of vitiligo, its pathogenesis, and the limitations of conventional treatments while highlighting recent advancements in LNPs-based drug delivery systems as a promising strategy for the effective management of vitiligo.
Camel Ghee: Nutritional Value and Health Aspects Syed Muzammil Munawar, Khaleel Basha Sabjan, Aafrin Waziri, Meena Bhandari, Renu Kadian, et al. Ghee Chemistry Technology and Health Aspects, 2023
Synthesis Approaches for Higher Yields of Nanoparticles Md. Sabir Alam, Md. Farhan Naseh, Jamilur R. Ansari, Aafrin Waziri, Md. Noushad Javed, et al. Nanomaterials in the Battle Against Pathogens and Disease Vectors, 2022
New Hopes for the Treatment of COVID-19 and Their Mechanistic Approaches: Future Prospective MSA Charu Bharti, Rabiya Parveen, Neelam Singh, Ekta Sirohi, Nandini Sharma ... Coronaviruses 1 (1), DOI: 10.2174/012666797536271725121011492 , 2026 2026
Poly-herbal hydrogel formulation for topical skin infection: Formulation development and characterization MSA Lalit, Jayamanti Pandit, Swati Chitranshi, Ashutosh Upadhayay INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES 4 (3), 443-455 , 2026 2026
New approaches of green silver hashtag#nanoparticles for cancer and biomedical applications: a review MSA Puja Kumari, Khushi Quadri, Renu Kadian, Saloni Mishra, Aafrin Waziri ... Exploration of Targeted Anti-tumor Therapy 6 (1), 1002341 (29) , 2025 2025 Citations: 8
Recent innovations in nanomedicine and nano-based techniques for the treatment of breast cancer M Bhandari, S Raj, MS Alam BioImpacts: BI 15, 30804 , 2025 2025 Citations: 4
Lipid-based nanoparticles: advancing therapeutic strategies for vitiligo management M Darvishi, AM Chekeni, M Fazelhosseini, S Rajabalizadeh, ... BioImpacts: BI 15, 30860 , 2025 2025 Citations: 2
Eco-friendly synthesis of Azadirachta indica-based metallic nanoparticles for biomedical application & future prospective P Kumari, L Devi, R Kadian, A Waziri, MS Alam Pharmaceutical Nanotechnology 13 (3), 448-464 , 2025 2025 Citations: 8
Role of nanomedicine for targeted drug delivery in livestock: future prospective N Hooda, A Ahlawat, P Kumari, MS Alam, JR Ansari Pharmaceutical Nanotechnology 13 (3), 479-496 , 2025 2025 Citations: 6
Vesicular carriers for stimuli-responsive drug delivery to tumors: design considerations MSA Shivali Rahi, Jayamanti Pandit, Khushi Quadri, Charu Bharti Tumor-Targeting with Stimuli-Responsive Vesicular Nanocarriers 1, 29-64 , 2025 2025 Citations: 1
EXPLORING GENERAL AWARENESS AND ATTITUDES TOWARDS DISPOSAL PRACTICE & STORAGE CONDITION OF MEDICATION AMONG THE GENERAL PUBLIC AT ACHROL, JAIPUR, RAJASTHAN (INDIA): A CROSS … TY Mazhar Jamil, Ashutosh Upadhayay, Md Sabir Alam, Vikram Kumar, Aafrin ... Indian Journal of Health Care, Medical & Pharmacy Practice 6 (1), 49-60 , 2025 2025
An Updated Review on the Alarming Epidemic of the Monkeypox Virus N Singh, MS Alam, C Bharti, N Kumar, S Jayant, Reetu, A Sharma Coronaviruses 6 (1), E290224227546 , 2025 2025
Herbal based nanoparticles as a possible and potential treatment of cancer: a review R Yadav, HS Chawra, G Dubey, MS Alam, V Kumar, P Sharma, ... Exploration of Targeted Anti-tumor Therapy 6, 1002285 , 2025 2025 Citations: 20
A new era of nanotechnology applied in neurological disease treatments J Pandit, C Bharti, S Gupta, SM Munawar, KB Sabjan, K Quadri, A Waziri, ... Essential Guide to Neurodegenerative Disorders, 499-522 , 2025 2025 Citations: 1
Potential role of probiotics for neurological disease treatment K Quadri, R Kadian, S Thakur, S Chaturvedi, G Rawat, A Waziri, MS Alam Essential Guide to Neurodegenerative Disorders, 479-497 , 2025 2025 Citations: 1
New Aspects of the Medicinal Value of Cornsilk: A Review P Bhatia, S Chaturvedi, S Shrivastav, MS Alam The Natural Products Journal 15 (1), E140324227982 , 2025 2025 Citations: 2
New approaches to the treatment of metabolic dysfunction-associated steatotic liver with natural products P Yadav, K Quadri, R Kadian, A Waziri, P Agrawal, MS Alam Iliver 3 (4), 100131 , 2024 2024 Citations: 12
Development and Characterization of Nanoparticulate Hydrogel Loaded with Extract of Fernandoa Adenophylla VKTY Roshan Yadav, Himmat Singh Chawra, Gaurav Dubey, Md. Sabir Alam Current Nanomedicine 1 (1), 29 , 2024 2024 Citations: 1
New emerging aspect of herbal extracts for the treatment of osteoporosis: overview P Kumari, RK Shirumalla, V Bhalla, MS Alam Current Rheumatology Reviews 20 (4), 361-372 , 2024 2024 Citations: 2
The treatment of psoriasis via herbal formulation and nano- polyherbal formulation: A new approach MSA Tejpal Yadav, Hemant Kumar Singh Yadav, Abhay Raizaday BioImpacts 1 (15), 30341 (1-21) , 2024 2024 Citations: 11
The Influence of Phytoconstituents for the Management of Antipsoriatic Activity in Various Animal Models AS Ravina Yadav, Tejpal Yadav, Ashutosh Upadhayay, Md Sabir Alam, Gaurav ... Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 1 (1), 1875-614X , 2024 2024 Citations: 2
Therapeutic potential of myricetin in the treatment of neurological, neuropsychiatric, and neurodegenerative disorders NK Sethiya, N Ghiloria, A Srivastav, D Bisht, SK Chaudhary, V Walia, ... CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 23 … , 2024 2024 Citations: 26
MOST CITED SCHOLAR PUBLICATIONS
Purple heart plant leaves extract-mediated silver nanoparticle synthesis: Optimization by Box-Behnken design MS Hasnain, MN Javed, MS Alam, P Rishishwar, S Rishishwar, S Ali, ... Materials Science and Engineering: C 99, 1105-1114 , 2019 2019 Citations: 206
Lipid-based nanoformulations in the treatment of neurological disorders GEBGMA Faheem Hyder Pottoo, Shrestha Sharma, Md. Noushad Javed, Md. Abul ... Drug Metabolism Reviews, 1-20 , 2020 2020 Citations: 123
Gum ghatti mediated, one pot green synthesis of optimized gold nanoparticles: Investigation of process-variables impact using Box-Behnken based statistical design MS Alam, A Garg, FH Pottoo, MK Saifullah, AI Tareq, O Manzoor, ... International journal of biological macromolecules 104, 758-767 , 2017 2017 Citations: 98
Bioinspired nanocomposites: applications in disease diagnosis and treatment S Mishra, S Sharma, MN Javed, FH Pottoo, MA Barkat, Harshita, MS Alam, ... Pharmaceutical nanotechnology 7 (3), 206-219 , 2019 2019 Citations: 97
Pharmaceutical quality by design: principles and applications S Beg, MS Hasnain Academic Press , 2019 2019 Citations: 96
The synergistic effect of raloxifene, fluoxetine, and bromocriptine protects against pilocarpine-induced status epilepticus and temporal lobe epilepsy FH Pottoo, N Tabassum, MN Javed, S Nigar, R Rasheed, A Khan, ... Molecular neurobiology 56 (2), 1233-1247 , 2019 2019 Citations: 86
Estrogen and serotonin: complexity of interactions and implications for epileptic seizures and epileptogenesis FH Pottoo, MN Javed, MA Barkat, MS Alam, JA Nowshehri, DM Alshayban, ... Current Neuropharmacology 17 (3), 214-231 , 2019 2019 Citations: 82
QbD applications for the development of nanopharmaceutical products MN Javed, MS Alam, A Waziri, FH Pottoo, AK Yadav, MS Hasnain, ... Pharmaceutical quality by design, 229-253 , 2019 2019 Citations: 72
Review on Natural Bioactive Products as Radioprotective Therapeutics :Present & Past Perspective, AMS Raj Seema, Manchanda Romila, Bhandari Meena* Current Pharmaceutical Biotechnology 1 (2022; 23() .), 1873-4316 , 2022 2022 Citations: 68
QbD approached comparison of reaction mechanism in microwave synthesized gold nanoparticles and their superior catalytic role against hazardous nirto‐dye F MD Sabir Alam, MD Noushad Javed, Fahim Hyder Putto, Arun Garg, Mohammad ... applied organometallic chemistry , 2019 2019 Citations: 68
Recent Advancement in Clinical Application of Nanotechnological Approached Targeted Delivery of Herbal Drugs FHP Md Noushad Javed, Ekta Singh Dahiya, Abdallah Mohammad Ibrahim, Md ... Nanophytomedicine 1 (https://link.springer.com/chapter/10.100), 151-172 , 2020 2020 Citations: 67
Raloxifene potentiates the effect of fluoxetine against maximal electroshock induced seizures in mice FH Pottoo, N Tabassum, MN Javed, S Nigar, S Sharma, MA Barkat, ... European Journal of Pharmaceutical Sciences 146, 105261 , 2020 2020 Citations: 47
Carbon allotropes-based nanodevices: graphene in biomedical applications S Singhal, M Gupta, MS Alam, MN Javed, JR Ansari Nanotechnology, 241-269 , 2022 2022 Citations: 38
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases MSAAKV Namrata Kumari, Nagarjuna Daram CNS & Neurological Disorders - Drug Targets 1 (1), 10.2174 … , 2022 2022 Citations: 37
Lipid nanocarriers for neurotherapeutics: Introduction, challenges, blood-brain barrier, and promises of delivery approaches M Aslam, MN Javed, HH Deeb, MK Nicola, MA Mirza, MS Alam, ... CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 21 … , 2022 2022 Citations: 36
Probiotics for the Chemoprotective Role Against the Toxic Effect of Cancer Chemotherapy MSA Aafrin Waziri, Charu Bharti, Mohammed Aslam, Parween Jamil, Aamir Mirza ... Anticancer Agents Med Chem . , 2021 2021 Citations: 36
Design of experiments for the development of nanoparticles, nanomaterials, and nanocomposites MN Javed, FH Pottoo, A Shamim, MS Hasnain, MS Alam Design of Experiments for Pharmaceutical Product Development: Volume II … , 2021 2021 Citations: 32
Therapeutic potential of myricetin in the treatment of neurological, neuropsychiatric, and neurodegenerative disorders NK Sethiya, N Ghiloria, A Srivastav, D Bisht, SK Chaudhary, V Walia, ... CNS & Neurological Disorders-Drug Targets-CNS & Neurological Disorders) 23 … , 2024 2024 Citations: 26
Metallic nanoparticle alone and/or in combination as novel agent for the treatment of uncontrolled electric conductance related disorders and/or seizure, epilepsy & convulsions MN Javed, FH Pottoo, MS Alam Patent acquired on October 10, 40 , 2016 2016 Citations: 26